Influence of yeast-based pre- and probiotics in lactation and nursery diets on nursery pig performance and antimicrobial resistance of fecal Escherichia coli.


Journal

Journal of animal science
ISSN: 1525-3163
Titre abrégé: J Anim Sci
Pays: United States
ID NLM: 8003002

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 28 04 2022
accepted: 03 05 2022
pubmed: 8 5 2022
medline: 9 6 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

Two experiments were conducted to determine the impact of various combinations of yeast-based direct fed microbials (DFM) in diets fed to nursery pigs weaned from sows fed lactation diets with or without yeast additives. In Exp. 1, 340 weaned pigs, initially 5.1 kg ± 0.02, were used to evaluate previous sow treatment (control vs. yeast additives) and nursery diets with or without added yeast-based DFM on growth performance and antimicrobial resistance (AMR) patterns of fecal Escherichia coli. Treatments were arranged in a 2 × 2 factorial with main effects of sow treatment (control vs. yeast-based pre- and probiotic diet; 0.10% ActiSaf Sc 47 HR+ and 0.025% SafMannan, Phileo by Lesaffre, Milwaukee, WI) and nursery treatment (control vs. yeast-based pre- and probiotic diet; 0.10% ActiSaf Sc 47 HR+, 0.05% SafMannan, and 0.05% NucleoSaf from days 0 to 7, then concentrations were decreased by 50% from days 7 to 24) with 5 pigs per pen and 17 replications per treatment. Progeny from sows fed yeast additives had increased (P < 0.05) average daily gain (ADG) from days 0 to 24 and days 0 to 45. However, pigs that were fed yeast additives for the first 24 d in the nursery tended to have decreased days 0 to 45 ADG (P = 0.079). Fecal E. coli isolated from pigs from the sows fed yeast group had increased (P = 0.034) resistance to nalidixic acid and a tendency for increased resistance to ciprofloxacin (P = 0.065) and gentamicin (P = 0.054). Yet, when yeast additives were added in the nursery, there was reduced (P < 0.05) fecal E. coli resistance to azithromycin and chloramphenicol. In Exp. 2, 330 weaned pigs, initially 5.8 kg ± 0.03, were used to evaluate diets with two different combinations of DFM on growth performance. Treatments were arranged in a 2 × 3 factorial with main effects of sow treatment (same as described in Exp. 1) and nursery treatment (control; YCW, 0.05% of SafMannan from days 0 to 38 and NucleoSaf at 0.05% from days 0 to 10 and 0.025% from days 10 to 24; or DFM, 0.10% MicroSaf-S from days 0 to 38 and NucleoSaf at 0.05% from days 0 to 10 and 0.025% from days 10 to 24) with 6 pigs per pen and 8 to 10 replications per treatment. From days 0 to 10 post-weaning, progeny of sows fed yeast additives had increased (P < 0.05) ADG and G:F. In conclusion, feeding sows yeast through lactation improved offspring growth performance in the nursery. Although feeding live yeast and yeast extracts reduced nursery pig performance in Exp. 1, feeding DFM improved growth later in the nursery period in Exp. 2. Feeding sows a diet containing live yeast and yeast extract from day 110 of gestation through weaning resulted in progeny that were heavier at weaning and had increased average daily gain and average daily feed intake throughout the nursery period. However, feeding yeast additives to pigs only in the nursery tended to reduce average daily gain. Fecal E. coli isolates from offspring that were fed yeast showed tendency towards antimicrobial resistance among fecal E. coli isolates to nalidixic acid, ciprofloxacin, and gentamicin. Yet, feeding live yeast and yeast extracts in the nursery phase may reduce the antimicrobial resistance of fecal E. coli to azithromycin and chloramphenicol.

Autres résumés

Type: plain-language-summary (eng)
Feeding sows a diet containing live yeast and yeast extract from day 110 of gestation through weaning resulted in progeny that were heavier at weaning and had increased average daily gain and average daily feed intake throughout the nursery period. However, feeding yeast additives to pigs only in the nursery tended to reduce average daily gain. Fecal E. coli isolates from offspring that were fed yeast showed tendency towards antimicrobial resistance among fecal E. coli isolates to nalidixic acid, ciprofloxacin, and gentamicin. Yet, feeding live yeast and yeast extracts in the nursery phase may reduce the antimicrobial resistance of fecal E. coli to azithromycin and chloramphenicol.

Identifiants

pubmed: 35524733
pii: 6582258
doi: 10.1093/jas/skac166
pmc: PMC9167580
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Oxford University Press on behalf of the American Society of Animal Science 2022.

Références

EMBO J. 1998 Nov 16;17(22):6437-48
pubmed: 9822590
Anim Nutr. 2017 Dec;3(4):331-343
pubmed: 29767089
J Anim Sci. 2019 Sep 3;97(9):3920-3937
pubmed: 31292631
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):60-6
pubmed: 19046775
Br J Nutr. 2017 Dec;118(11):949-958
pubmed: 29166952
J Anim Sci. 2015 May;93(5):2225-33
pubmed: 26020319
J Anim Sci. 2021 Dec 1;99(12):
pubmed: 34752618
J Anim Sci Biotechnol. 2013 Jan 07;4(1):1
pubmed: 23289727
J Anim Sci. 2011 Apr;89(4):1062-78
pubmed: 21148775
Vet Immunol Immunopathol. 2013 Mar 15;152(1-2):20-7
pubmed: 23092748
Nutr Res Rev. 2004 Dec;17(2):259-75
pubmed: 19079930
J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):300-305
pubmed: 29109626
Drugs. 1996 Jun;51(6):1019-74
pubmed: 8736621
Anim Nutr. 2021 Mar;7(1):84-93
pubmed: 33997335
Benef Microbes. 2019 Oct 14;10(7):773-799
pubmed: 31965849
Profiles Drug Subst Excip Relat Methodol. 2014;39:1-40
pubmed: 24794904
Anim Biotechnol. 2006;17(2):217-31
pubmed: 17127532
J Anim Sci. 2003 Mar;81(3):594-603
pubmed: 12661638
Drugs. 1988 Aug;36(2):193-228
pubmed: 3053126
Int J Mol Sci. 2021 Jan 15;22(2):
pubmed: 33467670
Anim Health Res Rev. 2005 Jun;6(1):17-39
pubmed: 16164007
J Anim Sci. 2003 Oct;81(10):2535-45
pubmed: 14552381
Sci Rep. 2018 Mar 28;8(1):5315
pubmed: 29593306
J Anim Sci. 2019 May 30;97(6):2534-2540
pubmed: 31067302
Antimicrob Agents Chemother. 1975 Sep;8(3):251-61
pubmed: 1101818
Animal. 2017 Jan;11(1):33-44
pubmed: 27358089
J Anim Sci. 2018 Dec 3;96(12):5166-5178
pubmed: 30358839
Vet Immunol Immunopathol. 2011 May 15;141(1-2):133-8
pubmed: 21354630
J Anim Sci. 2014 Feb;92(2):767-74
pubmed: 24305872
PLoS One. 2018 May 24;13(5):e0197586
pubmed: 29795617
J Anim Sci. 2012 Dec;90 Suppl 4:260-2
pubmed: 23365349
J Anim Sci. 2015 Sep;93(9):4336-42
pubmed: 26440333
J Anim Sci. 2009 Aug;87(8):2614-24
pubmed: 19395514
J Anim Sci. 2011 Aug;89(8):2462-71
pubmed: 21383042
Microorganisms. 2021 Apr 10;9(4):
pubmed: 33920300

Auteurs

Jenna A Chance (JA)

Department of Animal Sciences and Industry, Kanas State University, Manhattan, KS 66506-0201, USA.

Joel M DeRouchey (JM)

Department of Animal Sciences and Industry, Kanas State University, Manhattan, KS 66506-0201, USA.

Raghavendra G Amachawadi (RG)

Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-0201, USA.

Victor Ishengoma (V)

Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-0201, USA.

Tiruvoor G Nagaraja (TG)

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kanas State University, Manhattan, KS 66506-0201, USA.

Robert D Goodband (RD)

Department of Animal Sciences and Industry, Kanas State University, Manhattan, KS 66506-0201, USA.

Jason C Woodworth (JC)

Department of Animal Sciences and Industry, Kanas State University, Manhattan, KS 66506-0201, USA.

Mike D Tokach (MD)

Department of Animal Sciences and Industry, Kanas State University, Manhattan, KS 66506-0201, USA.

Qing Kang (Q)

Department of Statistics, College of Arts and Sciences, Kansas State University, Manhattan, KS 66506-0201, USA.

Joseph A Loughmiller (JA)

Phileo by Lesaffre, Milwaukee, WI 53214-1552, USA.

Brian Hotze (B)

Phileo by Lesaffre, Milwaukee, WI 53214-1552, USA.

Jordan T Gebhardt (JT)

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kanas State University, Manhattan, KS 66506-0201, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH